Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A qualitative study of patient-centered goal-setting in geriatric rehabilitation: patient and professional perspectives.

van Seben R, Smorenburg SM, Buurman BM.

Clin Rehabil. 2019 Jan;33(1):128-140. doi: 10.1177/0269215518791663. Epub 2018 Aug 14.

2.

Outcomes Associated With the Nationwide Introduction of Rapid Response Systems in The Netherlands.

Ludikhuize J, Brunsveld-Reinders AH, Dijkgraaf MG, Smorenburg SM, de Rooij SE, Adams R, de Maaijer PF, Fikkers BG, Tangkau P, de Jonge E; Cost and Outcomes of Medical Emergency Teams Study Group.

Crit Care Med. 2015 Dec;43(12):2544-51. doi: 10.1097/CCM.0000000000001272.

PMID:
26317569
3.

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.

Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, Asscheman H, de Rooij SE, Lie-A-Huen L, Smorenburg SM; WINGS Study Group.

PLoS One. 2013 Aug 5;8(8):e71045. doi: 10.1371/journal.pone.0071045. Print 2013.

4.

How nurses and physicians judge their own quality of care for deteriorating patients on medical wards: self-assessment of quality of care is suboptimal*.

Ludikhuize J, Dongelmans DA, Smorenburg SM, Gans-Langelaar M, de Jonge E, de Rooij SE.

Crit Care Med. 2012 Nov;40(11):2982-6. doi: 10.1097/CCM.0b013e31825fe2cb.

PMID:
22890255
5.

Association between acute geriatric syndromes and medication-related hospital admissions.

Wierenga PC, Buurman BM, Parlevliet JL, van Munster BC, Smorenburg SM, Inouye SK, de Rooij SE.

Drugs Aging. 2012 Aug 1;29(8):691-9. doi: 10.2165/11632510-000000000-00000.

6.

Recognition of adverse drug events in older hospitalized medical patients.

Klopotowska JE, Wierenga PC, Smorenburg SM, Stuijt CC, Arisz L, Kuks PF, Dijkgraaf MG, Lie-A-Huen L, de Rooij SE; WINGS study group.

Eur J Clin Pharmacol. 2013 Jan;69(1):75-85. doi: 10.1007/s00228-012-1316-4. Epub 2012 Jun 7.

7.

A checklist to improve patient safety in interventional radiology.

Koetser IC, de Vries EN, van Delden OM, Smorenburg SM, Boermeester MA, van Lienden KP.

Cardiovasc Intervent Radiol. 2013 Apr;36(2):312-9. doi: 10.1007/s00270-012-0395-z. Epub 2012 May 5.

8.

Nature and timing of incidents intercepted by the SURPASS checklist in surgical patients.

de Vries EN, Prins HA, Bennink MC, Neijenhuis P, van Stijn I, van Helden SH, van Putten MA, Smorenburg SM, Gouma DJ, Boermeester MA.

BMJ Qual Saf. 2012 Jun;21(6):503-8. doi: 10.1136/bmjqs-2011-000347. Epub 2012 Mar 23.

PMID:
22447822
9.

Identification of deteriorating patients on general wards; measurement of vital parameters and potential effectiveness of the Modified Early Warning Score.

Ludikhuize J, Smorenburg SM, de Rooij SE, de Jonge E.

J Crit Care. 2012 Aug;27(4):424.e7-13. doi: 10.1016/j.jcrc.2012.01.003. Epub 2012 Feb 14.

PMID:
22341727
10.

The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).

Klopotowska JE, Wierenga PC, de Rooij SE, Stuijt CC, Arisz L, Kuks PF, Dijkgraaf MG, Lie-A-Huen L, Smorenburg SM; WINGS study group.

BMC Health Serv Res. 2011 May 25;11:124. doi: 10.1186/1472-6963-11-124.

11.

Quality indicators for in-hospital pharmaceutical care of Dutch elderly patients: development and validation of an ACOVE-based quality indicator set.

Wierenga PC, Klopotowska JE, Smorenburg SM, van Kan HJ, Bijleveld YA, Dijkgraaf MG, de Rooij SE.

Drugs Aging. 2011 Apr 1;28(4):295-304. doi: 10.2165/11587700-000000000-00000.

PMID:
21428464
12.

Prevention of surgical malpractice claims by use of a surgical safety checklist.

de Vries EN, Eikens-Jansen MP, Hamersma AM, Smorenburg SM, Gouma DJ, Boermeester MA.

Ann Surg. 2011 Mar;253(3):624-8. doi: 10.1097/SLA.0b013e3182068880.

PMID:
21209590
13.

Effect of a comprehensive surgical safety system on patient outcomes.

de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH, Schlack WS, van Putten MA, Gouma DJ, Dijkgraaf MG, Smorenburg SM, Boermeester MA; SURPASS Collaborative Group.

N Engl J Med. 2010 Nov 11;363(20):1928-37. doi: 10.1056/NEJMsa0911535.

14.

On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.

Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, Vroom MB, Smorenburg SM.

Crit Care. 2010;14(5):R174. doi: 10.1186/cc9278. Epub 2010 Oct 4.

15.

The SURgical PAtient Safety System (SURPASS) checklist optimizes timing of antibiotic prophylaxis.

de Vries EN, Dijkstra L, Smorenburg SM, Meijer RP, Boermeester MA.

Patient Saf Surg. 2010 Apr 13;4(1):6. doi: 10.1186/1754-9493-4-6.

16.

Application of the Bow-Tie model in medication safety risk analysis: consecutive experience in two hospitals in the Netherlands.

Wierenga PC, Lie-A-Huen L, de Rooij SE, Klazinga NS, Guchelaar HJ, Smorenburg SM.

Drug Saf. 2009;32(8):663-73. doi: 10.2165/00002018-200932080-00005.

PMID:
19591531
17.

Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver.

Klerk CP, Niers TM, Brüggemann LW, Smorenburg SM, Richel DJ, Spek CA, Van Noorden CJ.

Thromb Res. 2010 Mar;125(3):235-8. doi: 10.1016/j.thromres.2009.03.005. Epub 2009 Apr 15. No abstract available.

PMID:
19371924
18.

Development and validation of the SURgical PAtient Safety System (SURPASS) checklist.

de Vries EN, Hollmann MW, Smorenburg SM, Gouma DJ, Boermeester MA.

Qual Saf Health Care. 2009 Apr;18(2):121-6. doi: 10.1136/qshc.2008.027524.

PMID:
19342526
19.

[A safer surgical pathway: monitoring in the operation room alone is insufficient].

de Vries EN, Smorenburg SM, Gouma DJ, Boermeester MA; SURPASS Implementatie Groep.

Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2491-4. Dutch.

PMID:
19055254
20.

The incidence and nature of in-hospital adverse events: a systematic review.

de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA.

Qual Saf Health Care. 2008 Jun;17(3):216-23. doi: 10.1136/qshc.2007.023622. Review.

21.

Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation.

Klerk CP, Smorenburg SM, Spek CA, Van Noorden CJ.

J Cell Mol Med. 2007 May-Jun;11(3):561-8.

22.

[Guideline for the non-pharmacological treatment of COPD].

Dekhuijzen PN, Smeele IJ, Smorenburg SM; Werkgroep Ketenzorg COPD.

Ned Tijdschr Geneeskd. 2006 Jun 3;150(22):1233-7. Dutch.

PMID:
16796174
23.

The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, Prandoni P, Bos MM, Richel DJ, van Tienhoven G, Büller HR.

J Clin Oncol. 2005 Apr 1;23(10):2130-5. Epub 2005 Feb 7.

PMID:
15699479
24.

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Klerk CP, Smorenburg SM, Büller HR.

Arch Intern Med. 2003 Sep 8;163(16):1913-21. Review.

PMID:
12963564
25.

Screening for cancer in patients with idiopathic venous thromboembolism: the clinical practice.

Otten JM, Smorenburg SM, de Meij MA, van der Schoor CA, Brandjes DP, Büller HR.

Pathophysiol Haemost Thromb. 2002 Mar-Apr;32(2):76-9.

26.

Inhibition of angiogenesis with heparin?

Smorenburg SM.

Haemostasis. 2001;31 Suppl 1:25-9. No abstract available.

PMID:
11990469
27.

The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis.

Smorenburg SM, Vink R, Otten HM, Swaneveld F, Büller HR.

Thromb Haemost. 2001 Dec;86(6):1586-7. Review. No abstract available.

PMID:
11776335
28.

Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor.

Otten HM, Prins MH, Smorenburg SM, Hutten BA.

Haemostasis. 2000;30 Suppl 2:72-6; discussion 63. Review.

PMID:
11251345
29.

The complex effects of heparins on cancer progression and metastasis in experimental studies.

Smorenburg SM, Van Noorden CJ.

Pharmacol Rev. 2001 Mar;53(1):93-105. Review.

PMID:
11171940
30.

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.

Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, van Hinsbergh VW.

Cancer Res. 2000 Nov 1;60(21):6196-200.

31.

In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Smorenburg SM, Vink R, te Lintelo M, Tigchelaar W, Maas A, Büller HR, van Noorden CJ.

Clin Exp Metastasis. 1999 Jul;17(5):451-6.

PMID:
10651313
32.

Should patients with venous thromboembolism and cancer be treated differently?

Smorenburg SM, Hutten BA, Prins MH.

Haemostasis. 1999 Dec;29 Suppl S1:91-7. Review.

PMID:
10629414
33.

The effects of unfractionated heparin on survival in patients with malignancy--a systematic review.

Smorenburg SM, Hettiarachchi RJ, Vink R, Büller HR.

Thromb Haemost. 1999 Dec;82(6):1600-4.

PMID:
10613641
34.

Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.

Hettiarachchi RJ, Smorenburg SM, Ginsberg J, Levine M, Prins MH, Büller HR.

Thromb Haemost. 1999 Aug;82(2):947-52. No abstract available.

PMID:
10605808
35.

Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver.

Griffini P, Fehres O, Klieverik L, Vogels IM, Tigchelaar W, Smorenburg SM, Van Noorden CJ.

Cancer Res. 1998 Aug 1;58(15):3312-9.

36.

Three-dimensional reconstruction of colon carcinoma metastases in liver.

Griffini P, Smorenburg SM, Verbeek FJ, van Noorden CJ.

J Microsc. 1997 Jul;187(Pt 1):12-21.

37.

Kupffer cells and pit cells are not effective in the defense against experimentally induced colon carcinoma metastasis in rat liver.

Griffini P, Smorenburg SM, Vogels IM, Tigchelaar W, Van Noorden CJ.

Clin Exp Metastasis. 1996 Sep;14(4):367-80.

PMID:
8878411
38.

alpha2-Macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver.

Smorenburg SM, Griffini P, Tiggelman AB, Moorman AF, Boers W, Van Noorden JF.

Hepatology. 1996 Mar;23(3):560-70.

PMID:
8617438

Supplemental Content

Loading ...
Support Center